{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:57:36Z","timestamp":1790729856828,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This systematic review and meta-analysis aimed to compare the short-term reproductive and long-term obstetric outcomes after endometrial preparations by ovarian stimulation protocols and hormone replacement therapy (HRT) in women with polycystic ovary syndrome (PCOS) prior to frozen embryo transfer (FET).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>PubMed, EMBASE, Web of Science and the Cochrane Library were searched to identify relevant studies. Primary outcome was live birth rate, secondary outcomes included the rates of clinical pregnancy, miscarriage, implantation and hCG-postive, cycle cancellation, ectopic pregnancy, preterm birth, preeclampsia, gestational hypertension, gestational diabetes mellitus and abnormal placentation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nine studies, including 8327 patients with PCOS, were identified. Live birth rate was significantly higher (RR\u2009=\u20091.11, 95% CI\u2009=\u20091.03\u20131.19) and miscarriage rate (RR\u2009=\u20090.60, 95% CI\u2009=\u20090.46\u20130.78) was significantly lower in stimulated protocol compared to the rates in HRT. While the rates of ongoing pregnancy, clinical pregnancy, implantation, hCG-positive, cycle cancellation and ectopic pregnancy showed no significant difference between the two protocols. Compared HRT with different stimulation protocols, significantly higher clinical pregnancy rate (RR\u2009=\u20091.54, 95% CI\u2009=\u20091.20\u20131.98) were found in letrozole group, but not in the other subgroups. For the obstetric outcomes, the preterm birth and preeclampsia rates were significantly lower in the stimulated group compared to that in the HRT group (RR\u2009=\u20090.85, 95% CI\u2009=\u20090.74\u20130.98; RR\u2009=\u20090.57, 95% CI\u2009=\u20090.40\u20130.82, respectively), while gestational hypertension, gestational diabetes mellitus and abnormal placentation rates showed no significant difference.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present data suggest that ovarian stimulation protocol as an endometrial preparation regimen prior to FET might be superior to HRT protocol with a significantly higher rate of live birth, lower risk of miscarriage, preterm birth and preeclampsia. Our study showed stimulated protocol is better than HRT regimen as an endometrial preparation for women with PCOS. However, quality of the evidence is low, more well-designed RCT studies are still needed to confirm the results before clinical recommendation, particularly direct comparisons between letrozole and other stimulated regimens.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-022-00931-4","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:03:35Z","timestamp":1648879415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Yingying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Chiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Pui Wah","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"931_CR1","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/humrep\/deab181","volume":"36","author":"S Palomba","year":"2021","unstructured":"Palomba S. Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. Hum Reprod. 2021;36:2421\u20138.","journal-title":"Hum Reprod"},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27:584\u2013618.","journal-title":"Hum Reprod Update"},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. Endocr Rev. 2009;30:1\u201350.","journal-title":"Endocr Rev"},{"key":"931_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/14647273.2014.961745","volume":"17","author":"RS Mathur","year":"2014","unstructured":"Mathur RS, Tan BK. British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2014;17:257\u201368.","journal-title":"Hum Fertil (Camb)"},{"key":"931_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.86080","volume":"4","author":"P Kumar","year":"2011","unstructured":"Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4:70\u20135.","journal-title":"J Hum Reprod Sci"},{"key":"931_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1055\/s-0037-1606383","volume":"35","author":"D Wei","year":"2017","unstructured":"Wei D, Ma J, Chen ZJ. Fresh versus Frozen Embryo Transfer in PCOS: Arguments for and Against. Semin Reprod Med. 2017;35:359\u201363.","journal-title":"Semin Reprod Med"},{"key":"931_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"Z-J Chen","year":"2016","unstructured":"Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N engl j med. 2016;375:523\u201333.","journal-title":"N engl j med"},{"key":"931_CR8","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/humrep\/dey253","volume":"33","author":"KD Le","year":"2018","unstructured":"Le KD, Vuong LN, Ho TM, Dang VQ, Pham TD, Pham CT, Norman RJ, Mol BWJ. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women. Hum Reprod. 2018;33:1907\u201314.","journal-title":"Hum Reprod"},{"key":"931_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10815-016-0773-6","volume":"33","author":"WT Teh","year":"2016","unstructured":"Teh WT, McBain J, Rogers P. What is the contribution of embryo-endometrial asynchrony to implantation failure? J Assist Reprod Genet. 2016;33:1419\u201330.","journal-title":"J Assist Reprod Genet"},{"key":"931_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"931_CR11","first-page":"6001","volume":"9","author":"W Xi","year":"2015","unstructured":"Xi W, Liu S, Mao H, Yang Y, Xue X, Lu X. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study. Drug Des Devel Ther. 2015;9:6001\u20138.","journal-title":"Drug Des Devel Ther"},{"key":"931_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09513590.2020.1867976","volume":"37","author":"MF Zeng","year":"2021","unstructured":"Zeng MF, Zhou X, Duan JL. Stimulated cycle versus artificial cycle for frozen embryo transfer in patients with polycystic ovary syndrome: a Meta-analysis. Gynecol Endocrinol. 2021;37:294\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"931_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12958-020-00675-z","volume":"18","author":"A Hosseini-Najarkolaei","year":"2020","unstructured":"Hosseini-Najarkolaei A, Moini A, Kashani L, Farid Mojtahedi M, Hosseini-Najarkolaee E, Salehi E. The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial. Reprod Biol Endocrinol. 2020;18:115.","journal-title":"Reprod Biol Endocrinol"},{"key":"931_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/jcm10040703","volume":"10","author":"N Aslih","year":"2021","unstructured":"Aslih N, Dorzia D, Atzmon Y, Estrada D, Ellenbogen A, Bilgory A, Shalom-Paz E. Ovulatory-Based FET Cycles May Achieve Higher Pregnancy Rates in the General Population and among Anovulatory Women. J Clin Med. 2021;10:703.","journal-title":"J Clin Med"},{"key":"931_CR15","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.2147\/DDDT.S317545","volume":"15","author":"L Li","year":"2021","unstructured":"Li L, Gao DD, Zhang Y, Song JY, Sun ZG. Comparison of Stimulated Cycles with Low Dose r-FSH versus Hormone Replacement Cycles for Endometrial Preparation Prior to Frozen-Thawed Embryo Transfer in Young Women with Polycystic Ovarian Syndrome: A Single-Center Retrospective Cohort Study from China. Drug Des Devel Ther. 2021;15:2805\u201313.","journal-title":"Drug Des Devel Ther"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/aogs.14058","volume":"100","author":"Y Man","year":"2021","unstructured":"Man Y, Bian Y, Zhao S, Zhao R, Xu X, Wei D, Li L, Chen ZJ, Zhao H. The effect of different endometrial preparations on women with polycystic ovary syndrome undergoing initial frozen embryo transfer: A historical cohort analysis. Acta Obstet Gynecol Scand. 2021;100:1116\u201323.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"931_CR17","doi-asserted-by":"publisher","first-page":"59 e51","DOI":"10.1016\/j.ajog.2021.01.024","volume":"225","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wei M, Bian X, Wu L, Zhang S, Mao X, Wang B. Letrozole-induced frozen embryo transfer cycles are associated with a lower risk of hypertensive disorders of pregnancy among women with polycystic ovary syndrome. Am J Obstet Gynecol. 2021;225:59 e51\u201359 e59.","journal-title":"Am J Obstet Gynecol"},{"key":"931_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12958-020-00601-3","volume":"18","author":"L Zong","year":"2020","unstructured":"Zong L, Liu P, Zhou L, Wei D, Ding L, Qin Y. Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer. Reprod Biol Endocrinol. 2020;18:36.","journal-title":"Reprod Biol Endocrinol"},{"key":"931_CR19","unstructured":"Higgins J: Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration.\u00a0https:\/\/www.cochrane-handbook.org.\u00a02011."},{"key":"931_CR20","first-page":"1","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"J Peterson","year":"2011","unstructured":"Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. p. 1\u201312."},{"key":"931_CR21","first-page":"557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses Bmj. 2003;327:557\u201360.","journal-title":"Measuring inconsistency in meta-analyses Bmj"},{"key":"931_CR22","doi-asserted-by":"crossref","unstructured":"Abstracts of the 32nd Annual Meeting of the European Society of Human Reproduction and Embryology. Human Reproduction.\u00a02016;31:i1\u2013i513.","DOI":"10.1093\/humrep\/31.Supplement_1.1"},{"key":"931_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/humrep\/dew120","volume":"31","author":"ER Groenewoud","year":"2016","unstructured":"Groenewoud ER, Cohlen BJ, Al-Oraiby A, Brinkhuis EA, Broekmans FJ, de Bruin JP, van den Dool G, Fleisher K, Friederich J, Goddijn M, et al. A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer. Hum Reprod. 2016;31:1483\u201392.","journal-title":"Hum Reprod"},{"key":"931_CR24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10815-019-01420-1","volume":"36","author":"S Jing","year":"2019","unstructured":"Jing S, Li XF, Zhang S, Gong F, Lu G, Lin G. Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle. J Assist Reprod Genet. 2019;36:925\u201333.","journal-title":"J Assist Reprod Genet"},{"key":"931_CR25","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/humrep\/deaa093","volume":"35","author":"B Wang","year":"2020","unstructured":"Wang B, Zhang J, Zhu Q, Yang X, Wang Y. Effects of different cycle regimens for frozen embryo transfer on perinatal outcomes of singletons. Hum Reprod. 2020;35:1612\u201322.","journal-title":"Hum Reprod"},{"key":"931_CR26","doi-asserted-by":"publisher","first-page":"546532","DOI":"10.3389\/fendo.2020.546532","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Li B, Wang Z, Wang Y, Gong X, Zhou W, Shi Y. Hormone Replacement Versus Natural Cycle Protocols of Endometrial Preparation for Frozen Embryo Transfer. Front Endocrinol (Lausanne). 2020;11:546532.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"931_CR27","doi-asserted-by":"publisher","first-page":"688237","DOI":"10.3389\/fendo.2021.688237","volume":"12","author":"S Mumusoglu","year":"2021","unstructured":"Mumusoglu S, Polat M, Ozbek IY, Bozdag G, Papanikolaou EG, Esteves SC, Humaidan P, Yarali H. Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review. Front Endocrinol (Lausanne). 2021;12:688237.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"931_CR28","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s10815-021-02307-w","volume":"38","author":"R Beck-Fruchter","year":"2021","unstructured":"Beck-Fruchter R, Nothman S, Baram S, Geslevich Y, Weiss A. Progesterone and estrogen levels are associated with live birth rates following artificial cycle frozen embryo transfers. J Assist Reprod Genet. 2021;38(11):2925\u201331.","journal-title":"J Assist Reprod Genet"},{"key":"931_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/humrep\/deaa092","volume":"35","author":"S Gaggiotti-Marre","year":"2020","unstructured":"Gaggiotti-Marre S, Alvarez M, Gonzalez-Foruria I, Parriego M, Garcia S, Martinez F, Barri PN, Polyzos NP, Coroleu B. Low progesterone levels on the day before natural cycle frozen embryo transfer are negatively associated with live birth rates. Hum Reprod. 2020;35:1623\u20139.","journal-title":"Hum Reprod"},{"key":"931_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/humrep\/deaa322","volume":"36","author":"E Labarta","year":"2021","unstructured":"Labarta E, Mariani G, Paolelli S, Rodriguez-Varela C, Vidal C, Giles J, Bellver J, Cruz F, Marzal A, Celada P. Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone. Hum Reprod. 2021;36:683\u201392.","journal-title":"Hum Reprod"},{"issue":"1","key":"931_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.fertnstert.2021.08.040","volume":"117","author":"E Labarta","year":"2021","unstructured":"Labarta E, Mariani G, Rodriguez-Varela C, Bosch E. Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles. Fertil Steril. 2021;117(1):96\u2013103.","journal-title":"Fertil Steril"},{"key":"931_CR32","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1210\/jc.2014-4235","volume":"100","author":"S Palomba","year":"2015","unstructured":"Palomba S. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015;100:1742\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"931_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2019.04.014","volume":"112","author":"J Zhang","year":"2019","unstructured":"Zhang J, Liu H, Wang Y, Mao X, Chen Q, Fan Y, Xiao Y, Kuang Y. Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome. Fertil Steril. 2019;112:371\u20137.","journal-title":"Fertil Steril"},{"issue":"10","key":"931_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/09513590.2019.1612358","volume":"35","author":"L Wang","year":"2019","unstructured":"Wang L, Wen X, Lv S, Zhao J, Yang T, Yang X. Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome: a randomized controlled study. Gynecological Endocrinology. 2019;35(10):862\u20135.","journal-title":"Gynecological Endocrinology"},{"key":"931_CR35","doi-asserted-by":"publisher","first-page":"532692","DOI":"10.3389\/fendo.2020.532692","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Lv S, Li F, Bai E, Yang X. Letrozole Versus Clomiphene Citrate and Natural Cycle: Endometrial Receptivity During Implantation Window in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2020;11:532692.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"931_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/jcpt.12831","volume":"44","author":"MT Al-Obaidi","year":"2019","unstructured":"Al-Obaidi MT, Ali ZH, Al-Saadi WI, Al-Wasiti EAR, Al-Aubaidy H. Impact of letrozole versus clomiphene citrate on endometrial receptivity in Iraqi women with polycystic ovarian syndrome. J Clin Pharm Ther. 2019;44:618\u201322.","journal-title":"J Clin Pharm Ther"},{"key":"931_CR37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00404-012-2478-0","volume":"286","author":"MI Ibrahim","year":"2012","unstructured":"Ibrahim MI, Moustafa RA, Abdel-Azeem AA. Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial. Arch Gynecol Obstet. 2012;286:1581\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"931_CR38","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/humrep\/dex066","volume":"32","author":"T Tatsumi","year":"2017","unstructured":"Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles. Hum Reprod. 2017;32:1244\u20138.","journal-title":"Hum Reprod"},{"key":"931_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/GRF.0b013e3182353d0f","volume":"54","author":"RF Casper","year":"2011","unstructured":"Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol. 2011;54:685\u201395.","journal-title":"Clin Obstet Gynecol"},{"key":"931_CR40","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2012.09.042","volume":"98","author":"JA Garcia-Velasco","year":"2012","unstructured":"Garcia-Velasco JA. The use of aromatase inhibitors in in vitro fertilization. Fertil Steril. 2012;98:1356\u20138.","journal-title":"Fertil Steril"},{"key":"931_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/19396368.2013.862316","volume":"60","author":"A Ganesh","year":"2014","unstructured":"Ganesh A, Chauhan N, Das S, Chakravarty B, Chaudhury K. Endometrial receptivity markers in infertile women stimulated with letrozole compared with clomiphene citrate and natural cycles. Syst Biol Reprod Med. 2014;60:105\u201311.","journal-title":"Syst Biol Reprod Med"},{"key":"931_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/humrep\/der452","volume":"27","author":"PB Miller","year":"2012","unstructured":"Miller PB, Parnell BA, Bushnell G, Tallman N, Forstein DA, Higdon HL 3rd, Kitawaki J, Lessey BA. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod. 2012;27:881\u20138.","journal-title":"Hum Reprod"},{"key":"931_CR43","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.2147\/DDDT.S212235","volume":"13","author":"J Lin","year":"2019","unstructured":"Lin J, Wang N, Huang J, Cai R, Fan Y, Kuang Y, Wang Y. Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study. Drug Des Devel Ther. 2019;13:3867\u201377.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"931_CR44","doi-asserted-by":"publisher","first-page":"59.e1","DOI":"10.1016\/j.ajog.2021.01.024","volume":"225","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wei M, Bian X, Wu L, Zhang S, Mao X, Wang B. Letrozole-induced frozen embryo transfer cycles are associated with a lower risk of hypertensive disorders of pregnancy among women with polycystic ovary syndrome. Am J Obstet Gynecol. 2021;225(1):59.e1\u201359.e9.","journal-title":"Am J Obstet Gynecol"},{"key":"931_CR45","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0015-0282(03)02165-4","volume":"80","author":"P Licht","year":"2003","unstructured":"Licht P, Russu V, Lehmeyer S, Wissentheit T, Siebzehnrubl E, Wildt L. Cycle dependency of intrauterine vascular endothelial growth factor levels is correlated with decidualization and corpus luteum function. Fertil Steril. 2003;80:1228\u201333.","journal-title":"Fertil Steril"},{"key":"931_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/rmb2.12280","volume":"18","author":"Y Fukui","year":"2019","unstructured":"Fukui Y, Hirota Y, Matsuo M, Gebril M, Akaeda S, Hiraoka T, Osuga Y. Uterine receptivity, embryo attachment, and embryo invasion: Multistep processes in embryo implantation. Reprod Med Biol. 2019;18:234\u201340.","journal-title":"Reprod Med Biol"},{"issue":"4","key":"931_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dmab003","volume":"27","author":"MM Pereira","year":"2021","unstructured":"Pereira MM, Mainigi M, Strauss JF. Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update. 2021;27(4):651\u201372.","journal-title":"Hum Reprod Update"},{"key":"931_CR48","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/humupd\/dmw021","volume":"22","author":"KP Conrad","year":"2016","unstructured":"Conrad KP. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin\/insulin-like family peptide receptor 1 for treatment and prevention. Hum Reprod Update. 2016;22:647\u201364.","journal-title":"Hum Reprod Update"},{"key":"931_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0035-1570379","volume":"33","author":"TK Morgan","year":"2016","unstructured":"Morgan TK. Role of the placenta in preterm birth: a review. Am J Perinatol. 2016;33:258\u201366.","journal-title":"Am J Perinatol"},{"key":"931_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","volume":"2","author":"JM Roberts","year":"2012","unstructured":"Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertension: An International Journal of Women\u2019s Cardiovascular Health. 2012;2:72\u201383.","journal-title":"Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health"},{"key":"931_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.preghy.2020.07.008","volume":"22","author":"EDP Uiterweer","year":"2020","unstructured":"Uiterweer EDP, Koster MP, Jeyabalan A, Kuc S, Siljee JE, Stewart DR, Conrad KP, Franx A. Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia. Pregnancy Hypertension. 2020;22:47\u201353.","journal-title":"Pregnancy Hypertension"},{"key":"931_CR52","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck F, Schaub AM, Chi Y-Y, Chiu K-H, Liu J, Lingis M, Stan Williams R, Rhoton-Vlasak A, Nichols WW, Fleischmann RR. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73:640\u20139.","journal-title":"Hypertension"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-00931-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T11:09:07Z","timestamp":1666350547000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-00931-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-00931-4","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have\u00a0no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}